Patient undergoing total knee replacement surgery for postoperative analgesia comparing 0.125% Bupivacaine and 0.2% Ropivacaine infusion for adductor canal block

Prospective randomized double-blind study to compare 0.125% Bupivacaine and 0.2% Ropivacaine infusion for adductor canal block after Total knee Arthroplasty for postoperative analgesia - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065671

Enrollment

Registered

2024-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Infusion of 0.125% Bupivacaine in adductor canal block: Dose - 0.125% Bupivacaine Route of Administration - catheter in adductor canal Duration - 2 days Rate - 7ml/hour Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing TKR. All the adult patients. ASA grade I and II. Patients giving consent for study.

Exclusion criteria

Exclusion criteria: Patients with coagulopathy. Allergy to local anaesthetics. Infection at the site of block.

Design outcomes

Primary

Measure	Time frame
Analgesic efficacy (VAS score 1-10) ; 10 is the worst pain. Timepoint: Analgesic efficacy (VAS score 1-10) ; 10 is the worst pain.	—

Secondary

Measure	Time frame
Total consumption of rescue analgesiaTimepoint: In 24 hour	—

Countries

India

Contacts

Public ContactDrMona Jadhav

D Y Patil School Of Medicine

monajadhav601@hotmail.com9763847148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026